Copyright Reports & Markets. All rights reserved.

Global Transforming Growth Factor Beta 1 Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Transforming Growth Factor Beta 1 Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Type
    • 1.4.2 Pirfenidone
    • 1.4.3 Galunisertib
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Application
    • 1.3.2 IPF
    • 1.3.3 Cancer
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Transforming Growth Factor Beta 1 Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Transforming Growth Factor Beta 1 Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Transforming Growth Factor Beta 1 Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Transforming Growth Factor Beta 1 Regions by Sales
    • 2.4.1 Global Top Transforming Growth Factor Beta 1 Regions by Sales (2016-2021)
    • 2.4.2 Global Top Transforming Growth Factor Beta 1 Regions by Sales (2022-2027)
  • 2.5 Global Top Transforming Growth Factor Beta 1 Regions by Revenue
    • 2.5.1 Global Top Transforming Growth Factor Beta 1 Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Transforming Growth Factor Beta 1 Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Transforming Growth Factor Beta 1 Sales by Manufacturers
    • 3.1.1 Global Top Transforming Growth Factor Beta 1 Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Transforming Growth Factor Beta 1 Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Transforming Growth Factor Beta 1 Sales in 2020
  • 3.2 Global Transforming Growth Factor Beta 1 Revenue by Manufacturers
    • 3.2.1 Global Top Transforming Growth Factor Beta 1 Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Transforming Growth Factor Beta 1 Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Transforming Growth Factor Beta 1 Revenue in 2020
  • 3.3 Global Transforming Growth Factor Beta 1 Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Transforming Growth Factor Beta 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Transforming Growth Factor Beta 1 Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Transforming Growth Factor Beta 1 Sales by Type
    • 4.1.1 Global Transforming Growth Factor Beta 1 Historical Sales by Type (2016-2021)
    • 4.1.2 Global Transforming Growth Factor Beta 1 Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2027)
  • 4.2 Global Transforming Growth Factor Beta 1 Revenue by Type
    • 4.2.1 Global Transforming Growth Factor Beta 1 Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Transforming Growth Factor Beta 1 Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2016-2027)
  • 4.3 Global Transforming Growth Factor Beta 1 Price by Type
    • 4.3.1 Global Transforming Growth Factor Beta 1 Price by Type (2016-2021)
    • 4.3.2 Global Transforming Growth Factor Beta 1 Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Transforming Growth Factor Beta 1 Sales by Application
    • 5.1.1 Global Transforming Growth Factor Beta 1 Historical Sales by Application (2016-2021)
    • 5.1.2 Global Transforming Growth Factor Beta 1 Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2027)
  • 5.2 Global Transforming Growth Factor Beta 1 Revenue by Application
    • 5.2.1 Global Transforming Growth Factor Beta 1 Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Transforming Growth Factor Beta 1 Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2016-2027)
  • 5.3 Global Transforming Growth Factor Beta 1 Price by Application
    • 5.3.1 Global Transforming Growth Factor Beta 1 Price by Application (2016-2021)
    • 5.3.2 Global Transforming Growth Factor Beta 1 Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Transforming Growth Factor Beta 1 Market Size by Type
    • 6.1.1 North America Transforming Growth Factor Beta 1 Sales by Type (2016-2027)
    • 6.1.2 North America Transforming Growth Factor Beta 1 Revenue by Type (2016-2027)
  • 6.2 North America Transforming Growth Factor Beta 1 Market Size by Application
    • 6.2.1 North America Transforming Growth Factor Beta 1 Sales by Application (2016-2027)
    • 6.2.2 North America Transforming Growth Factor Beta 1 Revenue by Application (2016-2027)
  • 6.3 North America Transforming Growth Factor Beta 1 Market Size by Country
    • 6.3.1 North America Transforming Growth Factor Beta 1 Sales by Country (2016-2027)
    • 6.3.2 North America Transforming Growth Factor Beta 1 Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Transforming Growth Factor Beta 1 Market Size by Type
    • 7.1.1 Europe Transforming Growth Factor Beta 1 Sales by Type (2017-2027)
    • 7.1.2 Europe Transforming Growth Factor Beta 1 Revenue by Type (2017-2027)
  • 7.2 Europe Transforming Growth Factor Beta 1 Market Size by Application
    • 7.2.1 Europe Transforming Growth Factor Beta 1 Sales by Application (2017-2027)
    • 7.2.2 Europe Transforming Growth Factor Beta 1 Revenue by Application (2017-2027)
  • 7.3 Europe Transforming Growth Factor Beta 1 Market Size by Country
    • 7.3.1 Europe Transforming Growth Factor Beta 1 Sales by Country (2017-2027)
    • 7.3.2 Europe Transforming Growth Factor Beta 1 Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Transforming Growth Factor Beta 1 Market Size by Type
    • 8.1.1 Asia Pacific Transforming Growth Factor Beta 1 Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Transforming Growth Factor Beta 1 Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Transforming Growth Factor Beta 1 Market Size by Application
    • 8.2.1 Asia Pacific Transforming Growth Factor Beta 1 Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Transforming Growth Factor Beta 1 Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Transforming Growth Factor Beta 1 Market Size by Region
    • 8.3.1 Asia Pacific Transforming Growth Factor Beta 1 Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Transforming Growth Factor Beta 1 Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Transforming Growth Factor Beta 1 Market Size by Type
    • 9.1.1 Latin America Transforming Growth Factor Beta 1 Sales by Type (2019-2027)
    • 9.1.2 Latin America Transforming Growth Factor Beta 1 Revenue by Type (2019-2027)
  • 9.2 Latin America Transforming Growth Factor Beta 1 Market Size by Application
    • 9.2.1 Latin America Transforming Growth Factor Beta 1 Sales by Application (2019-2027)
    • 9.2.2 Latin America Transforming Growth Factor Beta 1 Revenue by Application (2019-2027)
  • 9.3 Latin America Transforming Growth Factor Beta 1 Market Size by Country
    • 9.3.1 Latin America Transforming Growth Factor Beta 1 Sales by Country (2019-2027)
    • 9.3.2 Latin America Transforming Growth Factor Beta 1 Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Transforming Growth Factor Beta 1 Market Size by Type
    • 6.1.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Transforming Growth Factor Beta 1 Market Size by Application
    • 6.2.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Transforming Growth Factor Beta 1 Market Size by Country
    • 6.3.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Roche
    • 11.1.1 Roche Corporation Information
    • 11.1.2 Roche Overview
    • 11.1.3 Roche Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Roche Transforming Growth Factor Beta 1 Product Description
    • 11.1.5 Roche Related Developments
  • 11.2 Shionogi Ltd
    • 11.2.1 Shionogi Ltd Corporation Information
    • 11.2.2 Shionogi Ltd Overview
    • 11.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Product Description
    • 11.2.5 Shionogi Ltd Related Developments
  • 11.3 Acceleron Pharma Inc
    • 11.3.1 Acceleron Pharma Inc Corporation Information
    • 11.3.2 Acceleron Pharma Inc Overview
    • 11.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Description
    • 11.3.5 Acceleron Pharma Inc Related Developments
  • 11.4 Genzyme Corp
    • 11.4.1 Genzyme Corp Corporation Information
    • 11.4.2 Genzyme Corp Overview
    • 11.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Product Description
    • 11.4.5 Genzyme Corp Related Developments
  • 11.5 Isarna Therapeutics GmbH
    • 11.5.1 Isarna Therapeutics GmbH Corporation Information
    • 11.5.2 Isarna Therapeutics GmbH Overview
    • 11.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Description
    • 11.5.5 Isarna Therapeutics GmbH Related Developments
  • 11.6 Scholar Rock
    • 11.6.1 Scholar Rock Corporation Information
    • 11.6.2 Scholar Rock Overview
    • 11.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Scholar Rock Transforming Growth Factor Beta 1 Product Description
    • 11.6.5 Scholar Rock Related Developments
  • 11.7 Sirnaomics Inc
    • 11.7.1 Sirnaomics Inc Corporation Information
    • 11.7.2 Sirnaomics Inc Overview
    • 11.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Description
    • 11.7.5 Sirnaomics Inc Related Developments
  • 11.8 Eli Lilly and Co
    • 11.8.1 Eli Lilly and Co Corporation Information
    • 11.8.2 Eli Lilly and Co Overview
    • 11.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Description
    • 11.8.5 Eli Lilly and Co Related Developments
  • 11.9 Formation Biologics Inc
    • 11.9.1 Formation Biologics Inc Corporation Information
    • 11.9.2 Formation Biologics Inc Overview
    • 11.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Description
    • 11.9.5 Formation Biologics Inc Related Developments
  • 11.10 Novartis AG
    • 11.10.1 Novartis AG Corporation Information
    • 11.10.2 Novartis AG Overview
    • 11.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 Novartis AG Transforming Growth Factor Beta 1 Product Description
    • 11.10.5 Novartis AG Related Developments
  • 11.1 Roche
    • 11.1.1 Roche Corporation Information
    • 11.1.2 Roche Overview
    • 11.1.3 Roche Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Roche Transforming Growth Factor Beta 1 Product Description
    • 11.1.5 Roche Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Transforming Growth Factor Beta 1 Value Chain Analysis
  • 12.2 Transforming Growth Factor Beta 1 Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Transforming Growth Factor Beta 1 Production Mode & Process
  • 12.4 Transforming Growth Factor Beta 1 Sales and Marketing
    • 12.4.1 Transforming Growth Factor Beta 1 Sales Channels
    • 12.4.2 Transforming Growth Factor Beta 1 Distributors
  • 12.5 Transforming Growth Factor Beta 1 Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Transforming Growth Factor Beta 1 Industry Trends
  • 13.2 Transforming Growth Factor Beta 1 Market Drivers
  • 13.3 Transforming Growth Factor Beta 1 Market Challenges
  • 13.4 Transforming Growth Factor Beta 1 Market Restraints

14 Key Findings in The Global Transforming Growth Factor Beta 1 Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Transforming Growth Factor Beta 1 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Transforming Growth Factor Beta 1 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Pirfenidone
    Galunisertib
    Others

    Segment by Application
    IPF
    Cancer
    Others

    By Company
    Roche
    Shionogi Ltd
    Acceleron Pharma Inc
    Genzyme Corp
    Isarna Therapeutics GmbH
    Scholar Rock
    Sirnaomics Inc
    Eli Lilly and Co
    Formation Biologics Inc
    Novartis AG

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now